FDA Grants 510(k) Clearance to Retia Medical's Argos Infinity Cardiovascular Software Platform
Feb 17, 2026
The U.S. Food and Drug Administration has granted 510(k) clearance for Argos Infinity, Retia Medical's cardiovascular intelligence software platform designed for high-risk surgical and critical care environments across health systems.